JP2004256395A5 - - Google Patents

Download PDF

Info

Publication number
JP2004256395A5
JP2004256395A5 JP2003045510A JP2003045510A JP2004256395A5 JP 2004256395 A5 JP2004256395 A5 JP 2004256395A5 JP 2003045510 A JP2003045510 A JP 2003045510A JP 2003045510 A JP2003045510 A JP 2003045510A JP 2004256395 A5 JP2004256395 A5 JP 2004256395A5
Authority
JP
Japan
Prior art keywords
leukocyte migration
migration ability
leukocytes
agent
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003045510A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004256395A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003045510A priority Critical patent/JP2004256395A/ja
Priority claimed from JP2003045510A external-priority patent/JP2004256395A/ja
Publication of JP2004256395A publication Critical patent/JP2004256395A/ja
Publication of JP2004256395A5 publication Critical patent/JP2004256395A5/ja
Pending legal-status Critical Current

Links

JP2003045510A 2003-02-24 2003-02-24 白血球遊走能調節剤 Pending JP2004256395A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003045510A JP2004256395A (ja) 2003-02-24 2003-02-24 白血球遊走能調節剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003045510A JP2004256395A (ja) 2003-02-24 2003-02-24 白血球遊走能調節剤

Publications (2)

Publication Number Publication Date
JP2004256395A JP2004256395A (ja) 2004-09-16
JP2004256395A5 true JP2004256395A5 (cg-RX-API-DMAC7.html) 2005-07-14

Family

ID=33112290

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003045510A Pending JP2004256395A (ja) 2003-02-24 2003-02-24 白血球遊走能調節剤

Country Status (1)

Country Link
JP (1) JP2004256395A (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2911483C (en) * 2013-04-09 2022-10-04 The University Of Tokyo Inhibitor of extracellular trap formation in leukocytes

Similar Documents

Publication Publication Date Title
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
DE60042598D1 (de) Medikamente zur behandlung des syndroms der chronishen ermüdung, das mit fibromyalgie und reizdarm assoziert ist.
WO2005084638A3 (en) Formulations decreasing infectivity of pulmonary diseases
ATE508740T1 (de) Mittel zur verringerung von müdigkeit
NO20061917L (no) Belagt metal pyrition partikler for behandling av mikroorganismer
JP2006507295A5 (cg-RX-API-DMAC7.html)
CA2504872A1 (en) Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
Kaur et al. Dietary antioxidants and infectious diseases
WO2004047829A8 (en) New synergistic combination comprising roflumilast and formoterol
WO2008075333A3 (en) Edible compositions for preventing hair loss
JP2005187427A5 (cg-RX-API-DMAC7.html)
JP2018043942A5 (cg-RX-API-DMAC7.html)
Ross A high-metabolite immunogen from fermented yeast extract: balancing and strengthening immune response
WO2007057436A3 (en) Interferon in influenza
WO2005080549A3 (de) Trioxacarcine und deren verwendung gegen infektionskrankheiten
ATE399544T1 (de) Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol
JP2006160721A5 (cg-RX-API-DMAC7.html)
Alhiti Nanosilver plus Bacteriophages Cured COVID
PRADEEP et al. LITERATURE REVIEW OF CORONA VIRUS
JP2010507649A5 (cg-RX-API-DMAC7.html)
US20160175443A1 (en) Treatment options for allergies
TH1901004240A (th) องค์ประกอบอาหารสัตว์สำหรับการป้องกันหรือการรักษาโรคตับและตับอ่อนตายแบบเฉียบพลัน(AHPND)หรือกลุ่มอาการจุดขาว(WSS)ซึ่งประกอบรวมด้วยสายพันธุ์Bacillussubtilisที่เป็นส่วนประกอบออกฤทธิ์
WO2008036157A3 (en) Prophylactic and therapeutic treatment of avian influenza infections in animals
GB202102507D0 (en) Chemical for the treatment, prevention and control of virus's diseases, bacterial diseases, cardiovascular diseases and lipids
Beveridge Ethics & effectiveness: prevention, treatment and research for the global pandemic of injury